The criteria we use to decide if our patient is an appropriate candidate for our program are BMI (Body mass index of 25 kg/m2 or higher or the presence of one or more weight-related conditions like high blood pressure, type 2 diabetes, high cholesterol, increased risk of cardiovascular disease, fatty liver or metabolic syndrome
Weight Loss In addition to improving glycemic control, GLP-1 RAs demonstrate a benefit on body weight
This delayed gastric emptying increases feelings of fullness and helps reduce calorie intake, making it highly effective for weight loss
While it may not lower cholesterol as dramatically as statins, its multi-faceted approach can benefit patients, especially those with type 2 diabetes and obesity
No, semaglutide does usually show up on drug tests
Many reasons might explain this, like what you eat, how active you are, the dose youre on, and how your metabolism reacts